Volume 133, Issue 2, Pages (April 2008)

Slides:



Advertisements
Similar presentations
Volume 138, Issue 2, Pages (July 2009)
Advertisements

Volume 35, Issue 4, Pages (August 2009)
Volume 55, Issue 1, Pages (July 2014)
Volume 19, Issue 4, Pages (August 2005)
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy  Yongchao Zhao, Xiufang Xiong,
Shitao Li, Lingyan Wang, Michael A. Berman, Ye Zhang, Martin E. Dorf 
by Guang Yang, Shu-Ching Huang, Jane Y. Wu, and Edward J. Benz
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
Volume 36, Issue 2, Pages (October 2009)
Volume 18, Issue 17, Pages (September 2008)
A Mechanism for Inhibiting the SUMO Pathway
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Human mRNA Export Machinery Recruited to the 5′ End of mRNA
Yingqun Huang, Renata Gattoni, James Stévenin, Joan A. Steitz 
Communication with the Exon-Junction Complex and Activation of Nonsense-Mediated Decay by Human Upf Proteins Occur in the Cytoplasm  Guramrit Singh, Steffen.
Peroxisome Proliferator-Activated Receptor-α Is a Functional Target of p63 in Adult Human Keratinocytes  Silvia Pozzi, Michael Boergesen, Satrajit Sinha,
Volume 37, Issue 6, Pages (March 2010)
Volume 130, Issue 4, Pages (August 2007)
Ras Induces Mediator Complex Exchange on C/EBPβ
Stefanie S. Schalm, Diane C. Fingar, David M. Sabatini, John Blenis 
Volume 29, Issue 3, Pages (February 2008)
Direct Interactions of OCA-B and TFII-I Regulate Immunoglobulin Heavy-Chain Gene Transcription by Facilitating Enhancer-Promoter Communication  Xiaodi.
Esther B.E. Becker, Azad Bonni  Neuron 
Volume 43, Issue 6, Pages (September 2011)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
Gracjan Michlewski, Jeremy R. Sanford, Javier F. Cáceres 
Volume 38, Issue 3, Pages (May 2010)
Yingqun Huang, Joan A. Steitz  Molecular Cell 
PRAS40 Is an Insulin-Regulated Inhibitor of the mTORC1 Protein Kinase
Volume 26, Issue 6, Pages (September 2013)
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Volume 125, Issue 5, Pages (June 2006)
Shijiao Huang, Danming Tang, Yanzhuang Wang  Developmental Cell 
Volume 10, Issue 1, Pages (July 2002)
MyoD Targets TAF3/TRF3 to Activate Myogenin Transcription
Septins Regulate Actin Organization and Cell-Cycle Arrest through Nuclear Accumulation of NCK Mediated by SOCS7  Brandon E. Kremer, Laura A. Adang, Ian.
Zain Paroo, Xuecheng Ye, She Chen, Qinghua Liu  Cell 
c-Src Activates Endonuclease-Mediated mRNA Decay
The Actin-Bundling Protein Palladin Is an Akt1-Specific Substrate that Regulates Breast Cancer Cell Migration  Y. Rebecca Chin, Alex Toker  Molecular.
Volume 30, Issue 3, Pages (March 2009)
Phosphorylation on Thr-55 by TAF1 Mediates Degradation of p53
Volume 9, Issue 3, Pages (March 2009)
Volume 6, Issue 3, Pages (September 2000)
Volume 26, Issue 6, Pages (June 2007)
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15  Larissa A. Durfee, Nancy Lyon,
Volume 138, Issue 2, Pages (July 2009)
Volume 25, Issue 5, Pages (March 2007)
Amanda O'Donnell, Shen-Hsi Yang, Andrew D. Sharrocks  Molecular Cell 
The ISG15 Conjugation System Broadly Targets Newly Synthesized Proteins: Implications for the Antiviral Function of ISG15  Larissa A. Durfee, Nancy Lyon,
Yap1 Phosphorylation by c-Abl Is a Critical Step in Selective Activation of Proapoptotic Genes in Response to DNA Damage  Dan Levy, Yaarit Adamovich,
Volume 125, Issue 4, Pages (May 2006)
Hua Gao, Yue Sun, Yalan Wu, Bing Luan, Yaya Wang, Bin Qu, Gang Pei 
Volume 13, Issue 15, Pages (August 2003)
Volume 129, Issue 6, Pages (June 2007)
Disassembly of Exon Junction Complexes by PYM
Volume 29, Issue 1, Pages (January 2008)
Volume 16, Issue 16, Pages (August 2006)
Volume 38, Issue 1, Pages (April 2010)
Volume 18, Issue 2, Pages (August 2015)
Oliver I. Fregoso, Shipra Das, Martin Akerman, Adrian R. Krainer 
Volume 36, Issue 6, Pages (December 2009)
Phosphorylation of CBP by IKKα Promotes Cell Growth by Switching the Binding Preference of CBP from p53 to NF-κB  Wei-Chien Huang, Tsai-Kai Ju, Mien-Chie.
Volume 55, Issue 1, Pages (July 2014)
Volume 2, Issue 4, Pages (October 2012)
Volume 14, Issue 1, Pages (July 2013)
A Smad Transcriptional Corepressor
A Splicing-Independent Function of SF2/ASF in MicroRNA Processing
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Volume 41, Issue 4, Pages (February 2011)
Presentation transcript:

Volume 133, Issue 2, Pages 303-313 (April 2008) SKAR Links Pre-mRNA Splicing to mTOR/S6K1-Mediated Enhanced Translation Efficiency of Spliced mRNAs  Xiaoju Max Ma, Sang-Oh Yoon, Celeste J. Richardson, Kristina Jülich, John Blenis  Cell  Volume 133, Issue 2, Pages 303-313 (April 2008) DOI: 10.1016/j.cell.2008.02.031 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 Rapamycin-Sensitive mTOR/S6K1 Signaling on CBP80-Bound mRNPs (A) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs. CBP80-bound mRNPs were immunoprecipitated (IP) using anti-CBP80 antibody from cells treated as indicated. The phosphorylation of putative S6K1 substrates was determined by immunoblotting with anti-RXRXXpS/T motif antibody. Immunoblotting with anti-phospho-S6 (Ser 240/244) antibody was performed to confirm the recognition of phospho-S6 by the motif antibody. Potential S6K1 substrates were indicated with arrowheads. (B) Activated S6K1 and mTOR interact with CBP80-bound mRNPs. HEK293E cells were transfected with HA-tagged CBP80. Forty-eight hours posttransfection, the eIF3 complex, and mRNPs associated with HA-CBP80 or eIF4E were immunoprecipitated as described and their interaction with mTOR and S6K1 determined by immunoblotting. Normal rabbit serum (NRS) was used as a negative control in the experiments. These data are representative of greater than three experiments. Note that due to differences in the amount of eIF3 in the eIF3b IPs versus the HA-CBP80 and eIF4E IPs, thus resulting in differences in exposure times, the eIF3b immunoblots have been spliced together. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 2 SKAR Is Preferentially Associated with CBP80-Bound mRNPs (A) Immunoprecipitated CBP80-bound mRNPs contain SKAR. HEK293E cells were cotransfected with Flag-Upf3b and HA-CBP80. Twenty-four hours posttransfection, CBP80 and eIF4E mRNPs were immunoprecipitated. The association of SKAR and Flag-Upf3b with CBP80-bound mRNPs was determined by immunoblotting. (B) SKAR coimmunoprecipitates endogenous CBP80. SKAR was immunoprecipitated and assayed for interaction with endogenous CBP80. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 3 SKAR Is Preferentially Associated with Spliced mRNPs (A) SKAR is concentrated in nuclear speckles. U2OS or HeLa cells were fixed and costained for SKAR (panels a and d), or HA-SKAR (g), and for SC35 to localize nuclear speckles (b, e, and h). A merge of the two images is shown with yellow indicating areas of colocalization (c, f, and i). (B) Schematic of AdML pre-mRNA and intronless RNA control. MS2 is a bacteriophage protein, which recognizes the MS2 tag shown at the 3′ end of RNAs. (C) SKAR copurifies with spliceosomes and/or spliced mRNPs. Left panel: Total RNAs from the initial splicing reaction (input), or eluted fractions from the amylose affinity resin (elution) were separated by 8% denaturing PAGE and visualized by phosphorimager analysis. Uniformly 32P-labeled AdML pre-mRNA and spliced mRNA (spliced), and intronless mRNA (control) are indicated. Right panel: Immunoblotting of the initial splicing reaction (input), or eluted fractions (elution) using the indicated antibodies. These data are representative of greater than three experiments. (D) The ratio between HA-SKAR and endogenous SKAR was shown by immunoblotting with anti-SKAR antibodies. (E) SKAR is preferentially associated with spliced mRNA. Uniformly 32P-labeled AdML pre-mRNA (lane 5) and intronless mRNA (lane 1) were both incubated for 90 min under splicing conditions, followed by immunoprecipitation with indicated antibodies. One-tenth of total reaction was loaded as input. RNAs were separated by 15% denaturing PAGE. Structures of splicing substrates, intermediates and products are diagrammed. These data are representative of greater than five experiments. (F) Splicing reaction and immunoprecipitation were carried out as described in (E) except that uniformly 32P-labeled Ftz pre-mRNA was used as splicing substrate. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 4 SKAR Is Deposited on the EJC and Shuttles to the Cytoplasm (A) Generating the EJC-protected fragments. Splicing time courses for AdML pre-mRNA containing a site-specific 32P label at 20 nt upstream of the 5′ splice site (left panel; lanes 2-6). “☆” represents the site-specific 32P-label. “Con.” stands for control AdML mRNA was labeled at the equivalent position and incubated under the same conditions for 90 min (left panel; lane 1). Complete RNase A digestion at each time point yielded the EJC-protected fragment of ∼19 nt in length (right panel; lanes 4–6). RNA fragments were analyzed by a 20% denaturing PAGE. (B) SKAR is associated with the EJC. The EJC-protected fragment was immunoprecipitated with the indicated antibodies. One-tenth of the input was loaded. The RNA fragment with the site-specific 32P-label is illustrated. These data are representative of greater than three experiments. (C) SKAR interacts with other components of the EJC in an RNase-resistant manner. SKAR was immunoprecipitated from cell lysates, and its interaction with eIF4AIII was determined by immunoblotting. RNase A treatment was carried out at 20°C for 20 min before adding antibody. CBP80 was used as the negative control under conditions where RNase digestion was applied. (D) SKAR is a nucleocytoplasmic shuttling protein. Heterokaryons were produced as described in Experimental Procedures. Cells were stained with DAPI (right) and with anti-HA antibodies (left), while GFP-hnRNP C1 was directly visualized (middle). Arrowheads indicate mouse nuclei. A heterokaryon is shown by the arrow on the left. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 5 SKAR and eIF4AIII Mediate Phosphorylation of S6K1 Putative Targets in CBP80-Bound mRNPs (A) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs requires SKAR. HEK293E cells were infected with different shRNA-encoding viruses to induce RNAi-mediated gene-specific knockdowns. Forty-eight hours postinfection, cells were transfected with SBP-CBP80 plasmid or empty vector as control. Gene-specific knockdown was determined by immunoblotting with indicated antibodies, and the phosphorylation of putative S6K1 substrates in cell lysates was determined by anti-RXRXXpS/T motif antibody (left panels). CBP80-bound mRNPs were affinity purified using streptavidin-conjugated resin, and the phosphorylation of putative S6K1 substrates in the mRNPs was determined by anti-RXRXXpS/T motif antibody (right panel). Potential S6K1 substrates were indicated with arrowheads. Immunoblotting with anti-phospho-S6 (Ser 240/244) antibody was used to confirm the recognition of phospho-S6 by the motif antibody. (B) The interaction between activated S6K1 and CBP80-bound mRNP is significantly reduced by RNAi depletion of SKAR. Gene specific knockdowns were prepared as described in (A). Cells were then transfected with HA-CBP80 plasmid. Forty-eight hours posttransfection, CBP80 and eIF4E-associated mRNPs were immunoprecipitated using anti-HA and anti-eIF4E antibodies, respectively. The presence of activated S6K1 in the mRNPs was determined by immunoblotting with the indicated antibodies. (C) Phosphorylation of putative S6K1 substrates in CBP80-bound mRNPs requires the EJC core protein eIF4AIII. RNAi-mediated knockdown of eIF4AIII, affinity purification of CBP80-bound mRNPs and immunoblotting were performed as described in (A) and (B). Potential S6K1 substrates were indicated with arrowheads. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 6 S6K1, SKAR, and eIF4AIII Contribute to the Enhanced Translational Yield Gained by Splicing (A) Schematic of TPI/Renilla luciferase reporter constructs and Firefly control construct (Nott et al., 2003, 2004). TPI: the sixth intron and flanking exons from the human triose phosphate isomerase gene. (B) Rapamycin antagonizes the enhanced translational yield gained by splicing. HEK293E cells were transfected with reporter constructs and serum starved. Forty-eight hours posttransfection, cells were stimulated with insulin or pretreated with rapamycin and stimulated with insulin for additional 4 or 16 hr. Luciferase activities were measured by a dual-luciferase assay. After normalization to the cotransfected firefly control, the intron-containing/intronless Renilla luciferase light unit ratio was calculated as described in Experimental Procedures. Experiments were carried out in triplicate. Data are presented as the mean ± SEM (left panel). mRNA levels of Renilla and Firefly genes were monitored using semiquantitative RT-PCR analysis (right panel). PCR reactions without reverse transcription (RT-) served as controls. A titration of RNA quantity used in PCR reactions served to ensure the PCR reactions were quantitative. (C) S6K1, SKAR, and eIF4AIII modulate splicing-dependent enhancement of translation. HEK293E cells with gene-specific knockdowns were generated as in Figure 5. Cells were transfected with the reporter constructs and serum starved. 48 hr posttransfection, cells were stimulated with insulin. Luciferase activities were measured and calculated. Data are presented as the mean ± SEM (left panel). mRNA levels of Renilla and Firefly genes were monitored using semiquantitative RT-PCR (right panel). (D) Reduction of individual gene expression induced by shRNA-mediated gene knockdown was determined by immunoblotting with the indicated antibodies. Cell 2008 133, 303-313DOI: (10.1016/j.cell.2008.02.031) Copyright © 2008 Elsevier Inc. Terms and Conditions